Your browser doesn't support javascript.
loading
The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges.
Malik, Jonaid Ahmad; Ahmed, Sakeel; Mir, Aroosa; Shinde, Mrunal; Bender, Onur; Alshammari, Farhan; Ansari, Mukhtar; Anwar, Sirajudheen.
Affiliation
  • Malik JA; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Guwahati, India; Department of Biomedical Engineering, Indian Institute of Technology (IIT), Ropar 140001, India.
  • Ahmed S; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Ahmedabad, India.
  • Mir A; Department of Pharmacology, Jamia Hamdard, New Delhi, India.
  • Shinde M; Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research, Guwahati, India.
  • Bender O; Biotechnology Institute, Ankara University, Ankara, Turkey.
  • Alshammari F; Department of Pharmaceutics, College of Pharmacy, University of Hail, Hail, Saudi Arabia.
  • Ansari M; Department of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia.
  • Anwar S; Department of Pharmacology & Toxicology, College of Pharmacy, University of Hail, Hail, Saudi Arabia. Electronic address: si.anwar@uoh.edu.sa.
J Infect Public Health ; 15(2): 228-240, 2022 Feb.
Article in En | MEDLINE | ID: mdl-35042059

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / COVID-19 Limits: Humans Language: En Journal: J Infect Public Health Journal subject: DOENCAS TRANSMISSIVEIS / SAUDE PUBLICA Year: 2022 Document type: Article Affiliation country: India Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / COVID-19 Limits: Humans Language: En Journal: J Infect Public Health Journal subject: DOENCAS TRANSMISSIVEIS / SAUDE PUBLICA Year: 2022 Document type: Article Affiliation country: India Country of publication: United kingdom